Compugen (CGEN) Common Equity (2009 - 2026)

Compugen has disclosed Common Equity across 18 years of filings, most recently posting $95.4 million for Q1 2026.

• Common Equity for Q1 2026 came in at $95.4 million, up 66.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $95.4 million (up 66.97% YoY), and the FY2025 annual result was $102.7 million, up 87.08% from the prior year.
• Common Equity came in at $95.4 million for Q1 2026 at Compugen, down from $102.7 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $102.7 million in Q4 2025 to a low of $43.8 million in Q3 2025.
• The 5-year median for Common Equity is $62.0 million (2023), against an average of $69.3 million.
• Across the five-year window, Common Equity sank 33.32% in 2023 and surged 87.08% in 2025, its largest moves.
• Compugen's Common Equity stood at $77.7 million in 2022, then dropped by 15.6% to $65.6 million in 2023, then slipped by 16.24% to $54.9 million in 2024, then jumped by 87.08% to $102.7 million in 2025, then dropped by 7.18% to $95.4 million in 2026.
• The last three Common Equity figures came in at $95.4 million (Q1 2026), $102.7 million (Q4 2025), and $43.8 million (Q3 2025), per Business Quant data.